Effects of Lactobacillus rhamnosus GG on the cell growth and polyamine metabolism in HGC-27 human gastric cancer cells

Nutrition and Cancer

Volumn 59, Issue 1, 2007, Pages 106-114

  Russo, Francesco ^a   Orlando, Antonella ^a   Linsalata, Michele ^a   Cavallini, Aldo ^a   Messa, Caterina ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; LACTOBACILLUS RHAMNOSUS GG EXTRACT; MESSENGER RNA; POLYAMINE; PROBIOTIC AGENT; PROTEIN BAX; PROTEIN BCL 2; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL CELL WALL; CANCER CELL CULTURE; CANCER GROWTH; CELL FREE SYSTEM; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOPLASM; DNA SYNTHESIS; DRUG EFFECT; HUMAN; HUMAN CELL; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS RHAMNOSUS GG; NICK END LABELING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER;

BACTERIA (MICROORGANISMS); LACTOBACILLUS RHAMNOSUS;

EID: 35148814791     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701365084     Document Type: Article

References (35)

1. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, et al.: Functional food science and gastrointestinal physiology and function. Br J Nutr 80, S147-S171, 1998.
2. Cremonini F, Di Caro S, Nista EC, Bartolozzi F, Capelli G, et al.: Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 16, 1461-1467, 2002.
3. Hart AC, Stagg AJ, and Komm MA: Use of probiotics in the treatment of inflammatory bowel disease. J Clin Gastroenterol 36, 111-119, 2003.
4. O'Sullivan MP and O'Morain CA: Bacterial supplementation in the irritable bowel syndrome: a randomised double-blind placebo-controlled crossover study. Dig Liver Dis 32, 294-301, 2000.
5. Lin DC: Probiotics as functional foods. Nutr Clin Pract 18, 497-506, 2003.
6. Reddy BS: Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth. J Nutr 129, S1478-S1482, 1999.
7. Reddy BS: Prevention of colon cancer by pre- and probiotics: evidence from laboratory studies. Br J Nutr 80, 219-223, 1998.
8. Madsen KL: The use of probiotics in gastrointestinal disease. Can J Gastroenterol 15, 817-822, 2001.
9. Biancone L, Monteleone I, Del Vecchio Blanco G, Vavassori P, and Pallone F: Resident bacterial flora and immune system. Dig Liver Dis 34, S37-S43, 2002.
10. Erickson KL and Hubbard NE: Probiotic immunomodulation in health and disease. J Nutr 130, 403-409, 2000.
11. Linsalata M, Russo F, Berloco P, Valentini AM, Caruso ML, et al.: Effects of probiotic bacteria (VSL#3) on the polyamine biosynthesis and cell proliferation of normal colonic mucosa of rats. In Vivo 19, 989-995, 2005.
12. Linsalata M, Russo F, Berloco P, Caruso ML, Di Matteo G, et al.: The Influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori-infected gastric mucosa. Helicobacter 9, 165-172, 2004.
13. Ierardi E, Francavilla A, Balzano T, Traversa A, Principi M, et al.: Effect of Helicobacter pylori eradication on gastric epithelial proliferation: relationship with ras oncogenes p21 expression. Ital J Gastroenterol Hepatol 29, 214-219, 1997.
14. Linsalata M, Russo F, Notarnicola M, Berloco P, and Di Leo A: Polyamine profile in human gastric mucosa infected by Helicobacter pylori. Ital J Gastroenterol Hepatol 30, 484-489, 1998.
15. Tabor CW and Tabor H: Polyamines. Annu Rev Biochem 53, 749-790, 1984.
16. Pegg AE and McCann PP: Polyamines metabolism and function. Am J Physiol 243, C212-C221, 1982.
17. Linsalata M, Russo F, Cavallini A, Berloco P, and Di Leo A: Polyamines, diamine oxidase and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mucosa. Dis Colon Rectum 36, 662-667, 1993.
18. Garewal HS, Sloan D, Sampliner RE, and Fennerty B: Ornithine decarboxylase assay in human colorectal mucosa: methodological issues of importance to quality control. Int J Cancer 52, 355-358, 1992.
19. Messa C, Pricci M, Linsalata M, Russo F, and Di Leo A: Inhibitory effect 17β-estradiol growth polyamine metabolism a human gastric carcinoma cell line (HGC-27). Scand J Gastroenterol 34, 79-84, 1999.
20. Linsalata M, Giannini R, Notarnicola M, and Cavallini A: Peroxisome proliferator-activated receptor gamma and spermidine/spermine N1-acetyltransferase gene expressions are significantly correlated in human colorectal cancer. BMC Cancer 6, 191-197, 2006.
21. Burns AJ and Rowland IR: Anti-carcinogenicity of probiotics and prebiotics. Curr Issues Intest Microbiol 1, 13-24, 2000.
22. Santosa S, Farnworth E, and Jones PJ: Probiotics and their potential health claims. Nutr Rev 64, 265-274, 2006.
23. Conway PL, Gorbach SL, and Goldin BR: Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci 70, 1-12, 1987.
24. Thomas T and Thomas TJ: Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 58, 244-258, 2001.
25. Auvinen M, Paasinen A, Andersson LC, and Holtta E: Ornithine decarboxylase activity is critical for cell transformation. Nature 360, 355-358, 1992.
26. Deloyer P, Peulen O, and Dandrifosse G: Dietary polyamines and non-neoplastic growth and disease. Eur J Gastroenterol Hepatol 3, 1027-1032, 2001.
27. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, et al.: Bifidobacterium longum, a lactic acid-producing intestinal bacterium, inhibits colon cancer and modulates the intestinal biomarkers of colon carcinogenesis. Carcinogenesis 18, 833-841, 1997.
28. Carlson DA and Ribeiro JM: Apoptosis and disease. Lancet 341, 1251-1254, 1993.
29. Yan F and Polk DBJ: Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. Biol Chem 277, 50959-50965, 2002.
30. Lee JW, Shin JG, Kim EH, Kang HE, Yim IB, et al.: Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J Vet Sci 5, 41-48, 2004.
31. Pessi T, Sutas Y, Saxelin M, Kallioinen H, and Isolauri E: Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria. Appl Environ Microbiol 65, 4725-4728, 1999.
32. Bernet-Camard MF, Lievin V, Brassart D, Neeser JR, Servin AL, et al.: The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol 63, 2747-2753, 1997.
33. Zamfir M, Callewaert R, Cornea PC, Savu L, Vatafu I, et al.: Purification and characterization of a bacteriocin produced by Lactobacillus acidophilus IBB 801.J. Appl Microbiol 87, 923-931, 1999.
34. Ibnou-Zekri N, Blum S, Schiffrin EJ, and von der Weid T: Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun 71, 428-436, 2003.
35. Valeur N, Engel P, Carbajal N, Connolly N, and Ladefoged K: Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 70, 1176-1181, 2004.